[1]
2022. Immunomodulation of cancer cells by CAR-T, mAbs, CTLA-4 and targeted neoantigens. Electronic Journal Collection Health. 15, 3 (Mar. 2022), e9959. DOI:https://doi.org/10.25248/reas.e9959.2022.